共 72 条
[1]
Shulman L.E., Diffuse fasciitis with eosinophilia: a new syndrome?, Trans Assoc Am Physicians, 88, pp. 70-86, (1975)
[2]
Shulman L.E., Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?, J Rheumatol, 11, pp. 569-570, (1984)
[3]
Fett N., Arthur M., Eosinophilic fasciitis: current concepts, Clin Dermatol, 36, pp. 487-497, (2018)
[4]
Pinal-Fernandez I., Selva-O Callaghan A., Grau J.M., Diagnosis and classification of eosinophilic fasciitis, Autoimmun Rev, 13, pp. 379-382, (2014)
[5]
Lakhanpal S., Ginsburg W.W., Michet C.J., Et al., Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases, Semin Arthritis Rheum, 17, pp. 221-231, (1988)
[6]
Wright N.A., Mazori D.R., Patel M., Et al., Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers, JAMA Dermatol, 152, pp. 97-99, (2016)
[7]
Lebeaux D., Frances C., Barete S., Et al., Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients, Rheumatology, 51, pp. 557-561, (2012)
[8]
Mango R.L., Bugdayli K., Crowson C.S., Et al., Baseline characteristics and long-term outcomes of eosinophilic fasciitis in 89 patients seen at a single center over 20 years, Int J Rheum Dis, 23, pp. 233-239, (2020)
[9]
Chaigne B., Tieu A., Beeker N., Et al., Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128 patients with eosinophilic fasciitis, J Am Acad Dermatol, 87, pp. 997-1005, (2022)
[10]
Zuelgaray E., Chevret S., Jachiet M., Et al., Trunk involvement and peau d’orange aspect are poor prognostic factors in eosinophilic fasciitis (Shulman disease): a multicenter retrospective study of 119 patients, J Am Acad Dermatol, 88, pp. 160-163, (2023)